Skip to content

ABL800 Flex

by Radiometer Medical ApS

510(k) K041874

ABL800 Flex is a medical device (FDA Class II; FDA product code CHL, Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph) made by Radiometer Medical ApS, cleared under FDA 510(k) K041874 on 8 Oct 2004, active as of 9 Oct 2026. 21 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

4 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 9 Oct 2026.

Regulatory status

as of registry sync 9 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK041874 Date8 Oct 2004ClearedStatusActive

Official records

From the FDA record

Received by the FDA
12 Jul 2004
FDA decision
8 Oct 2004 (Substantially Equivalent)
FDA review time
88 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K041874 (openFDA), as read on 9 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

22 recalls · 4 ongoing · FDA

    • Ongoing Z-0190-2027 FDA Class II initiated 18 Aug 2026

    In vitro diagnostic analyzer had a risk of potentially inaccurate results requiring changes to instructions for use and: 1) Sample types, including whole blood samples no longer suitable for testing FHbF and ctBil, 2) Reportable ranges for some parameters, 3) Analyzer configuration, and 4) limitations and warnings.

    • Ongoing Z-2426-2024 FDA Class II initiated 31 May 2024

    Issue with analyzer when the pH of the calibration solution decreases during the in-use period potentially because of bacterial growth in the calibration solution bottles. This may result in a probability of reporting biased out-of-specification pH results on blood samples.

    • Ongoing Z-1321-2022 FDA Class II initiated 18 May 2022

    There is a potential for sporadic incidents of positive and negative biases for analyzer systems configured with cNa+, cCa+, and cK+.

    • Ongoing Z-1836-2020 FDA Class II initiated 6 Mar 2020

    Through internal investigation is has been determined that an incorrect component was used within the power supply. The incorrect component may cause a short circuit within the power supply resulting in a delay in treatment. The delay could result in a range of risk from cyanosis and low blood pressure to cardiac arrhythmias and severe impairment of cardiac function.

  • 2 recalls, same reason

    • Terminated Z-2494-2020 FDA Class II initiated 26 May 2020
    • Terminated Z-2493-2020 FDA Class II initiated 26 May 2020

    Potential risk of patient mix-up on analyzers due to software issues.

    • Terminated Z-1684-2020 FDA Class II initiated 10 Mar 2020

    Analyzer's barcode reader misinterprets the contents of barcode label used for entering patient ID or accession number. The issue is related to barcode types not using a check digit. This could result in patient mixup or loss of sample resulting in delayed medical treatment

    • Terminated Z-0682-2019 FDA Class II initiated 3 Jul 2018

    The analyzer software may cause a mis-match of patient demographics and test results when a certain sequence of events occur.

    • Terminated Z-0231-2018 FDA Class II initiated 24 Oct 2017

    Due to misinterpretation of the barcode by the scanner, when the registration receipt barcode is scanned by the analyzer , a result from a different patient will be printed or displayed on the analyzer.

    • Terminated Z-1463-2017 FDA Class II initiated 26 Jan 2017

    Reports that the sample type "cord blood" has been changed into the two sample types "cord blood arterial" and "cord blood venous.

    • Terminated Z-1075-2014 FDA Class II initiated 5 Jul 2013

    RADIOMETER has become aware that some D788 pCO2 membranes can cause biased measurement results on patient results as well as QC results.

  • 2 recalls, same reason

    • Terminated Z-2162-2012 FDA Class II initiated 5 Jul 2012
    • Terminated Z-2163-2012 FDA Class II initiated 5 Jul 2012

    A customer has reported an error on an ABL8xx configured to a Hospital Information System using the data transfer protocol HL7 version 2.5. If the instrument transmits results to a HIS system and the connection is broken the results are queued for later transmission. If the ABL and HIS system are configured with HL7 2.5, any results in the queue will be mixed up when the instrument transmits t

    • Terminated Z-1554-2009 FDA Unclassified (pre-2012) initiated 16 Apr 2009

    When removing the waste bottle from the analyzer waste material may leak both from the analyzer and from the waste bottle.

    • Terminated Z-1654-2008 FDA Unclassified (pre-2012) initiated 18 Jan 2008

    Reported calibration errors are not displayed on the analyzers parameter bar screen or on the patient results when the calibration number is between 32768 - 65535 and 98303 - 131070. This may cause the operator to perform measurements and obtain questionable results.

    • Terminated Z-0038-2008 FDA Unclassified (pre-2012) initiated 22 Jun 2007

    Tube may break. The firm discovered that the yellowish/white tubes used in their blood gas analyzers (ABL800 Flex Series) were manufactured incorrectly. These tubes have the potential to break off at the black plastic connectors. The breakage may occur during the installation of the tubes or after a short time in use.

    • Terminated Z-1095-2007 FDA Unclassified (pre-2012) initiated 13 Nov 2006

    Software anomaly. Protein removing program incorporated in the operating software for Versions: V3.833 and V5.24, of the ABL700 and ABL800 Blood Gas Analyzers, may allow for protein build up on the electrode membranes of blood gas analyzers. This condition can influence analyzer results. When the protein removal program is run too frequently, more than once a week, or when running the protein rem

    • Terminated Z-1325-06 FDA Unclassified (pre-2012) initiated 31 Oct 2005

    ABL800 Series Blood Gas Analyzer became inoperable when the 'restore default setup' button was touched.

    • Terminated Z-1387-06 FDA Unclassified (pre-2012) initiated 29 Sep 2005 on shared 510(k) K041874

    Under certain circumstances, the ABL 700 &800 Series Blood Gas Analyzers may experience leakage current into the measuring system. Consequently, the analyzers intermittently provide incorrect (too low) result values for Calcium (Ca) and Sodium (Na).

    • Terminated Z-1324-06 FDA Unclassified (pre-2012) initiated 19 Sep 2005

    Reference electrodes for the firm's ABL 700/800 Blood Gas Analyzers are oversized and will not fit into the instrument.

    • Terminated Z-1319-06 FDA Unclassified (pre-2012) initiated 17 Jun 2005

    The recalled membranes cause the status value of the pH and electrolyte electrodes to be offset causing readings outside of the acceptable range.

    • Terminated Z-1318-06 FDA Unclassified (pre-2012) initiated 17 Jun 2005

    Software defect. pO2 and pCO2 sample test results run on the firm's ABL700/800 Series Blood Gas Analyzers are not being properly flagged during the sample calibration phase.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

23 dated events

  1. Recall initiated FDA recalls Z-1463-2017
  2. Recall initiated FDA recalls Z-0231-2018
  3. Recall initiated FDA recalls Z-0682-2019
  4. Recall initiated FDA recalls Z-1836-2020
  5. Recall initiated FDA recalls Z-1684-2020
  6. Recall initiated FDA recalls Z-2494-2020
  7. Recall initiated FDA recalls Z-2493-2020
  8. Recall initiated FDA recalls Z-1321-2022
  9. Recall initiated FDA recalls Z-2426-2024
  10. Recall initiated FDA recalls Z-0190-2027

13 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
CHL
Device class
Class II
Regulation
21 CFR Part 862.1120
Advisory committee
Clinical Chemistry
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code CHL (Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph).

Other devices from Radiometer Medical ApS

See all devices from Radiometer Medical ApS →